A Phase 1 study of human lysozyme goat milk for GVHD prevention
Active, Not Recruiting Phase 1 NCT04177004
Study Description
A study evaluating the safety and feasibility of drinking human lysozyme goat milk to prevent graft versus host disease after a stem cell transplant for blood cancer
Study Details
- Registry ID:
- NCT04177004
- Conditions:
- Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm
- Phase:
- Phase 1
- Target Enrollment:
- 52 participants
- Start Date:
- Age Range:
- 12–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
City of Hope Medical Center
Duarte, California, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.